We are live on
!
Find out more
SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
51 hedge funds and large institutions have $129M invested in scPharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 20 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
360% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 5
233% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 6
55% more funds holding
Funds holding: 33 → 51 (+18)
40% more capital invested
Capital invested by funds: $92.4M → $129M (+$36.6M)
5.92% more ownership
Funds ownership: 59.54% → 65.46% (+5.9%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
51
Holders Change
+18
Holders Change %
+54.55%
% of All Funds
1.05%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
23
Increased
20
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
O
OrbiMed
New York
|
+$12.2M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$6.57M |
| 3 |
5VM
5AM Venture Management
San Francisco,
California
|
+$5.08M |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$3.47M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$3.41M |
Top Sellers
| 1 |
JP Morgan Chase
New York
|
-$346K |
| 2 |
Millennium Management
New York
|
-$259K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$220K |
| 4 |
MC
Matisse Capital
Portland,
Oregon
|
-$87.8K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$87K |
